ChromaDex
Mark Germain is an accomplished executive with extensive experience in the biopharmaceutical and biotech industries. Currently serving as the Chairman of the Board of Directors at Scinai Immunotherapeutics Ltd. since June 2018, Germain has previously held positions such as Vice Chairman from June 2018 to September 2019. As Managing Director of The Aentib Group since May 2014, Germain offers specialized advisory and investment solutions. Additionally, Germain advises Lunit Inc. and serves on the Board of Directors of both Lunit USA and HerronTech, where leadership is provided in developing innovative software solutions. A seasoned entrepreneur, Germain co-founded numerous biotech companies, including Alexion, Incyte, and ChromaDex, engaging in strategic corporate development initiatives. Germain holds a Juris Doctor degree from New York University School of Law.
This person is not in the org chart
This person is not in any teams
This person is not in any offices